mebendazole has been researched along with Leukemia L 1210 in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delatour, P | 1 |
| Lorgue, G | 1 |
| Lapras, M | 1 |
| Richard, Y | 1 |
1 other study available for mebendazole and Leukemia L 1210
| Article | Year |
|---|---|
[Embryotoxic and antimitotic properties of parbendazole, mebendazole and cambendazole].
Topics: Abnormalities, Drug-Induced; Animals; Benzimidazoles; Cambendazole; Carcinoma, Ehrlich Tumor; Embryo | 1976 |